Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Analysis of clozapine-induced seizures using the Japanese Adverse Drug Event Report database
Masakazu Hatano, Kaho Yamada, Haruna Matsuzaki, et al.
PLoS ONE (2023) Vol. 18, Iss. 6, pp. e0287122-e0287122
Open Access | Times Cited: 10

Showing 10 citing articles:

Second‐generation antipsychotic‐induced dystonia: Analysis using the Japanese Adverse Drug Event Report (JADER) database
Takumi Ebina, Kunihiro Iwamoto, Masahiko Ando, et al.
Psychiatry and Clinical Neurosciences (2025)
Open Access | Times Cited: 1
Optimizing co-prescription of clozapine and antiseizure medications: a systematic review and expert recommendations for clinical practice
Hélène Verdoux, Clélia Quilès, José de León
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 5, pp. 347-358
Closed Access | Times Cited: 5
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II
José de León, Ross J. Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Do psychotropic drugs cause seizures?
Margaret Gopaul, Hamada Altalib
Epilepsy & Behavior Reports (2024) Vol. 27, pp. 100679-100679
Open Access | Times Cited: 4
A Pharmacovigilance Study on Clozapine in the Food and Drug Administration Adverse Event Reporting System: A Regional Comparative Analysis
Masakazu Hatano, Haruna Araki, Takeo Saito, et al.
Clinical Psychopharmacology and Neuroscience (2024) Vol. 22, Iss. 3, pp. 442-450
Open Access | Times Cited: 3
Clozapine-associated adverse drug reactions in 38,349 psychiatric inpatients: drug surveillance data from the AMSP project between 1993 and 2016
Lene Bleich, R. Grohmann, W. Greil, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 9, pp. 1117-1134
Open Access | Times Cited: 2
A real-world disproportionality analysis of Baloxavir Marboxil: post-marketing pharmacovigilance data
Jie Zhou, Junchang Ye, Maohua Chen, et al.
Expert Opinion on Drug Safety (2024), pp. 1-9
Closed Access | Times Cited: 1
A pharmacovigilance study on clinical factors of active vitamin D3 analog-related acute kidney injury using the Japanese Adverse Drug Event Report Database
Yuki Kawai, Kazushi Uneda, Satoshi Miyata, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Clozapine: A special case of an atypical antipsychotic
Elina Marinho
European Journal of Medicinal Chemistry Reports (2024) Vol. 10, pp. 100140-100140
Open Access
Association Between Hypnotics, Accidents, and Injuries: A Study Based on the Adverse Drug Event Reporting Database in Japan
Rintaro Sogawa, Masakazu Hatano, Fusanori Nishimura, et al.
In Vivo (2024) Vol. 39, Iss. 1, pp. 433-439
Open Access
Seizure Incidence in Patients under Clozapine
A. Tounsi, F. Azraf, S. Belbachir, et al.
SAS Journal of Medicine (2023) Vol. 9, Iss. 09, pp. 924-928
Open Access
Page 1

Scroll to top